Global Ent Devices Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2024 –2031 |
 Размер рынка (базовый год) |
USD 2.15 Billion |
 Размер рынка (прогнозируемый год) |
USD 3.97 Billion |
 CAGR |
% |
| Основные игроки рынка |
>Глобальный рынок ЛОР-устройств по типу процедуры (тонзиллэктомия и аденоидэктомия, установка тимпаностомической трубки, септопластика, уменьшение носовых раковин, носовое кровотечение и гортань), конечный пользователь (ЛОР-клиники, больницы, амбулаторные учреждения и другие), канал сбыта (прямые тендеры, розничные продажи и онлайн-продажи) — тенденции отрасли и прогноз до 2031 года.
Анализ и размер рынка ЛОР-устройств
Глобальный рынок ЛОР-устройств стимулируется растущей распространенностью ЛОР-заболеваний из-за таких факторов, как старение населения, экологические факторы и изменения образа жизни, что приводит к увеличению спроса на диагностические и терапевтические устройства, такие как слуховые аппараты и эндоскопы. Однако рынок сталкивается с ограничением высокой стоимости устройств, что может ограничить доступность, особенно в развивающихся регионах. Технологические достижения открывают возможности для роста рынка, поскольку такие инновации, как минимально инвазивные процедуры и усовершенствованные конструкции устройств, улучшают результаты лечения пациентов. Ключевой проблемой является нехватка квалифицированных ЛОР-специалистов, особенно в развивающихся странах, что может препятствовать внедрению современных ЛОР-устройств и решений. Преодоление этих проблем при одновременном использовании технологических достижений может привести к значительному расширению рынка.
По данным исследования рынка Data Bridge, ожидается, что объем мирового рынка ЛОР-устройств к 2031 году достигнет 3,97 млрд долларов США по сравнению с 2,15 млрд долларов США в 2023 году, а среднегодовой темп роста составит 8,1% в прогнозируемый период с 2024 по 2031 год.
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2024-2031 |
|
Базовый год |
2023 |
|
Исторические годы |
2022 (настраиваемый 2016-2021) |
|
Количественные единицы |
Доход в млрд долларов США |
|
Охваченные сегменты |
Тип процедуры (тонзиллэктомия и аденоидэктомия, установка тимпаностомической трубки, септопластика, уменьшение носовых раковин, носовое кровотечение и гортань), конечный пользователь (ЛОР-клиники, больницы, амбулаторные учреждения и другие), канал сбыта (прямой тендер, розничные продажи и онлайн-продажи) |
|
Страны, охваченные |
США, Канада, Германия, Франция, Великобритания, Китай, Япония, Индия, Южная Корея, Австралия, Бразилия, Мексика, Колумбия, Чили, Южная Африка и Саудовская Аравия |
|
Охваченные участники рынка |
Smith+Nephew, Medtronic, Boston Scientific Corporation, KARL STORZ SE & CO. KG, Туттлинген, Olympus Corporation, Stryker, KLS Martin Group, Narang Medical Limited, Dimed Laser, biolitec GmbH & Co KG, IRIDEX Corporation, Symmetry Surgical Inc., Sutter Medical Technology GmbH, ARC Laser GmbH, ASCLEPION, Medency, ECO Medical и Advin Health Care и другие |
Определение рынка
ENT devices encompass a wide array of instruments and equipment crucial for diagnosing, treating, and managing disorders of the ear, nose, and throat. These devices include powered instruments, such as drills and shavers, used in surgeries to precisely cut and shape tissues. Electrocautery devices are employed to coagulate or remove tissues using high-frequency electrical currents, aiding in controlling bleeding. Radiofrequency wands are utilized for procedures like turbinate reduction, where they use radiofrequency energy to shrink nasal tissues. Cold steel instruments, traditional yet essential, are used for various cutting and dissecting tasks. These devices, alongside others like endoscopes and suction devices, play a pivotal role in enabling ENT specialists to perform a range of diagnostic and therapeutic procedures, ensuring effective patient care.
Global ENT Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increasing Prevalence of ENT Disorders
The global ENT devices market is witnessing significant growth driven by the increasing prevalence of Ear, Nose, and Throat (ENT) disorders. Conditions such as sinusitis, rhinitis, and obstructive sleep apnea are becoming more common, leading to a higher demand for effective treatment options. Chronic sinusitis, a prevalent ENT condition, affects a considerable part of the population and is characterized by inflammation and swelling of the sinuses, resulting in symptoms like nasal congestion and facial pain. The rising incidence of these ENT disorders has led to an increased demand for diagnostic and treatment options, driving the growth of the global ENT devices market. ENT devices are essential tools in the diagnosis and management of these conditions. As the incidence of these conditions continues to rise, there is a growing need for advanced diagnostic tools and treatment options. This trend is expected to fuel the growth of the ENT device market.
- Growing Elderly Population
The aging population is a significant factor contributing to the increasing demand for diagnostic and treatment devices in the field of Ear, Nose, and Throat (ENT) disorders. As people age, they are more susceptible to a variety of ENT conditions, including hearing loss, chronic sinusitis, and voice disorders. Age-related changes in the anatomy and function of the ear, nose, and throat can lead to these disorders, necessitating the need for specialized devices for diagnosis and treatment. Similarly, the prevalence of chronic sinusitis and voice disorders increases with age, driving the need for advanced diagnostic tools and treatment devices. The aging population is a key demographic trend that is expected to have a profound impact on the ENT device market. This demographic shift is driving the demand for innovative solutions to address the unique healthcare needs of the elderly population. Manufacturers are focusing on developing advanced diagnostic and treatment devices that are tailored to the specific needs of older patients.
Opportunity
- Rise in Procedure Numbers for ENT Treatment
The rise in procedure numbers for ENT treatment, including procedures such as Tonsillectomy & Adenoidectomy, Tympanostomy Tube Insertions, Septoplasty, Turbinate Reduction, Epistaxis, and Laryngeal procedures, serves as a significant opportunity for the ENT device market. The increasing prevalence of ear, nose, and throat disorders, coupled with advancements in medical technology, has led to a surge in the number of ENT procedures performed worldwide. As healthcare providers strive to meet the growing demand for ENT treatments, there is a corresponding need for advanced medical devices and instruments to support these procedures effectively. ENT devices such as surgical instruments, implants, etc. play a crucial role in enhancing the precision, safety, and efficiency of ENT surgeries. The surge in procedure numbers for ENT treatments is a pivotal opportunity propelling the ENT device market forward. As the demand for ENT procedures such as Tonsillectomy & Adenoidectomy, Tympanostomy Tube Insertions, Septoplasty, Turbinate Reduction, Epistaxis, and Laryngeal procedures continues to rise globally, there emerges a pressing need for sophisticated medical devices and instruments to support these interventions effectively. This increasing demand not only underscores the significance of advancements in medical technology but also creates a substantial market opportunity for ENT device manufacturers as expected to propel the market growth.
Restraint/Challenge
- High Initial Cost for ENT Laser Devices
The cost of ENT laser devices, presents a significant barrier to accessing essential diagnostic and treatment options for ENT conditions. For many patients, especially in developing countries, the high cost of ENT laser devices can be prohibitive, leading to delayed or inadequate care. This not only impacts individual patients' quality of life but also hinders the overall growth of the market by limiting the adoption of these devices. Furthermore, the financial burden of these devices can strain healthcare systems and providers, particularly in resource-constrained settings, leading to challenges in providing affordable and accessible care for ENT disorders. The high cost of ENT laser devices and treatments poses a considerable restraint on the market, particularly for patients and regions with limited financial resources.
Recent Developments
- In June 2024, Dimed Laser will exhibit at FIME 2024, the premier medical trade event in the Americas, connecting over 15,000 healthcare professionals and 1,300 exhibitors. This event offers a unique opportunity to discover cutting-edge products and engage in discussions about the future of healthcare
- In January 2024, Iridex Corporation announce the launch of its next-generation platform, the Iridex 532 and Iridex 577 Lasers, in the United States. This launch will enhance Iridex Corporation's product line and market presence, reinforcing its position as a leader in innovative laser-based medical systems for eye disease treatment
- In March 2023, Smith+Nephew, has announced new scientific research results demonstrating that its COBLATION Intracapsular Tonsillectomy (CIT) technique can improve post-operative outcomes compared to total tonsillectomy techniques. This research highlights the effectiveness of Smith+Nephew's COBLATION Intracapsular Tonsillectomy (CIT) technique, potentially boosting the company's reputation and market position in the field of tonsillectomy procedures
- In October 2022, Aspen Surgical Products, Inc., a leader in disposable surgical products and a portfolio company of Audax Private Equity, has announced the acquisition of Symmetry Surgical from RoundTable Healthcare Partners. This acquisition will expand Aspen Surgical's product portfolio and market presence, strengthening its position as a leader in disposable surgical products
- In May 2022, Medtronic plc announced that it has completed the acquisition of Intersect ENT, growing the company's comprehensive Ear, Nose, and Throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps
Global ENT Devices Market Scope
Глобальный рынок ЛОР-устройств сегментирован на три заметных сегмента на основе типа процедуры, конечного пользователя и канала сбыта. Рост среди этих сегментов поможет вам проанализировать основные сегменты роста в отраслях и предоставить пользователям ценный обзор рынка и рыночные идеи для принятия стратегических решений по определению основных рыночных приложений.
Тип процедуры
- Тонзиллэктомия и аденоидэктомия
- Введение тимпаностомической трубки
- Септопластика
- Редукция носовых раковин
- Носовое кровотечение
- Гортанный
По типу процедуры рынок сегментирован на тонзиллэктомию и аденоидэктомию, установку тимпаностомической трубки, септопластику, уменьшение носовых раковин, носовое кровотечение и операции на гортани.
Конечный пользователь
- ЛОР-клиники
- Больницы
- Амбулаторные учреждения
- Другие
По признаку конечного потребителя рынок сегментируется на ЛОР-клиники, больницы, амбулаторные учреждения и другие.
Канал распространения
- Прямой тендер
- Розничные продажи
- Онлайн-продажи
По каналу сбыта рынок сегментируется на прямые торги, розничные продажи и онлайн-продажи.
Региональный анализ/информация о мировом рынке ЛОР-устройств
Проведен анализ мирового рынка ЛОР-устройств, а также предоставлены сведения о размерах рынка и тенденциях на основе типа процедуры, конечного пользователя и канала сбыта, как указано выше.
В данном отчете о рынке рассматриваются следующие страны: США, Канада, Германия, Франция, Великобритания, Китай, Япония, Индия, Южная Корея, Австралия, Бразилия, Мексика, Колумбия, Чили, Южная Африка и Саудовская Аравия.
Ожидается, что Северная Америка будет доминировать на мировом рынке ЛОР-устройств из-за таких факторов, как высокие расходы на здравоохранение, развитая инфраструктура здравоохранения и большой пул пациентов с ЛОР-заболеваниями. Ожидается, что США будут доминировать на рынке ЛОР-устройств в Северной Америке из-за большого размера рынка здравоохранения и высоких показателей внедрения передовых ЛОР-устройств и процедур. Ожидается, что Германия будет доминировать на рынке ЛОР-устройств EMEA из-за своей сильной индустрии медицинских технологий, высоких стандартов здравоохранения и большой базы населения, требующей лечения и устройств, связанных с ЛОР-заболеваниями. Ожидается, что Китай будет доминировать на рынке ЛОР-устройств Азиатско-Тихоокеанского региона из-за своей огромной численности населения, растущих расходов на здравоохранение и быстрого прогресса в инфраструктуре здравоохранения и внедрении технологий.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости сверху и снизу, технические тенденции и анализ пяти сил Портера, тематические исследования, являются некоторыми из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы из-за большой или малой конкуренции со стороны местных и отечественных брендов, влияние внутренних тарифов и торговых путей.
Анализ конкурентной среды и доли мирового рынка ЛОР-устройств
Конкурентная среда мирового рынка ЛОР-устройств содержит сведения по конкурентам. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, инвестициях в исследования и разработки, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта и доминировании в применении. Приведенные выше данные касаются только фокуса компаний на мировом рынке ЛОР-устройств.
Среди основных игроков, работающих на мировом рынке ЛОР-устройств, можно назвать Smith+Nephew, Medtronic, Boston Scientific Corporation, KARL STORZ SE & CO. KG, Tuttlingen, Olympus Corporation, Stryker, KLS Martin Group, Narang Medical Limited, Dimed Laser, biolitec GmbH & Co KG, IRIDEX Corporation, Symmetry Surgical Inc., Sutter Medical Technology GmbH, ARC Laser GmbH, ASCLEPION, Medency, ECO Medical и Advin Health Care и другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL ENT DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF ENT DISORDERS
5.1.2 GROWING ELDERLY POPULATION
5.1.3 RISING REIMBURSEMENT TRENDS
5.1.4 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
5.2 RESTRAINTS
5.2.1 HIGH INITIAL COST FOR ENT LASER DEVICES
5.2.2 COMPLICATIONS AND RISKS ASSOCIATED WITH ENT PROCEDURES
5.3 OPPORTUNITIES
5.3.1 RISE IN PROCEDURE NUMBERS FOR ENT TREATMENT
5.3.2 STRATEGIC PARTNERSHIPS AND COLLABORATIONS IN THE ENT DEVICE INDUSTRY
5.3.3 CONTINUOUS TECHNOLOGICAL ADVANCEMENT IN ENT PROCEDURES
5.4 CHALLENGES
5.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS IN DEVELOPING COUNTRIES
5.4.2 PRESENCE OF NUMEROUS PLAYERS IN THE MARKET
6 GLOBAL ENT DEVICES MARKET, BY PROCEDURE TYPE
6.1 OVERVIEW
6.2 TONSILLECTOMY & ADENOIDECTOMY
6.2.1 POWERED INSTRUMENTS
6.2.2 ELECTROCAUTERY DEVICES
6.2.3 RADIO FREQUENCY WANDS
6.2.4 COLD STEEL
6.3 TYMPANOSTOMY TUBE INSERTIONS
6.4 SEPTOPLASTY
6.4.1 SEPTAL STAPLER
6.4.2 OTHER MODALITY/SUTURES
6.5 TURBINATE REDUCTION
6.5.1 RADIO FREQUENCY WANDS
6.5.2 POWERED INSTRUMENTS (SHAVER)
6.5.3 COLD STEEL
6.5.4 OTHER
6.6 EPISTAXIS
6.6.1 SILVER NITRATE
6.6.2 NASAL TAMPONADES
6.6.3 COAGULANTS
6.6.4 OTHERS
6.7 LARYNGEAL
6.7.1 LASER
6.7.2 POWERED INSTRUMENTS
6.7.3 RADIO FREQUENCY WANDS
6.7.4 COLD STEEL
7 GLOBAL ENT DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 ENT CLINICS
7.3 HOSPITALS
7.4 AMBULATORY SETTINGS
7.5 OTHERS
8 GLOBAL ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 RETAIL SALES
8.4 ONLINE SALES
9 GLOBAL ENT DEVICES MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 LATIN AMERICA
9.3.1 BRAZIL
9.3.2 MEXICO
9.3.3 COLUMBIA
9.3.4 CHILE
9.4 EUROPE AND MIDDLE EAST & AFRICA
9.4.1 GERMANY
9.4.2 U.K.
9.4.3 FRANCE
9.4.4 SOUTH AFRICA
9.4.5 SAUDI ARABIA
9.5 ASIA-PACIFIC
9.5.1 CHINA
9.5.2 INDIA
9.5.3 JAPAN
9.5.4 AUSTRALIA
9.5.5 SOUTH KOREA
10 GLOBAL ENT DEVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EMEA
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILES
12.1 SMITH+NEPHEW
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 MEDTRONIC
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 BOSTON SCIENTIFIC CORPORATION
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 KARL STORZ SE & CO. KG, TUTTLINGEN
12.4.1 COMPANY SNAPSHOT
12.4.2 COMPANY SHARE ANALYSIS
1.1.1 PRODUCT PORTFOLIO
12.4.3 RECENT DEVELOPMENT
12.5 OLYMPUS CORPORATION
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 A.R.C. LASER GMBH
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 ADVIN HEALTH CARE
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 ASCLEPION
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 BIOLITEC GMBH & CO KG
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 DIMED LASER
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 ECO MEDICAL
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENTS
12.12 IRIDEX CORPORATION
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENT
12.13 KLS MARTIN GROUP.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 MEDENCY
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENTS
12.15 NARANG MEDICAL LIMITED.
12.15.1 COMPANY SNAPSHOT
12.15.2 PRODUCT PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 STRYKER
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 PRODUCT PORTFOLIO
12.16.4 RECENT DEVELOPMENT
12.17 SUTTER MEDICAL TECHNOLOGY GMBH
12.17.1 COMPANY SNAPSHOT
12.17.2 PRODUCT PORTFOLIO
12.17.3 RECENT DEVELOPMENTS
12.18 SYMMETRY SURGICAL INC.
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
Список таблиц
TABLE 1 GLOBAL ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 2 GLOBAL TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 3 GLOBAL TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 5 GLOBAL TYMPANOSTOMY TUBE INSERTIONS IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL SEPTOPLASTY IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 9 GLOBAL TURBINATE REDUCTION IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 12 GLOBAL EPISTAXIS IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 15 GLOBAL LARYNGEAL IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 18 GLOBAL ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL ENT CLINICS IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL HOSPITALS IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL AMBULATORY SETTINGS IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL OTHERS IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL DIRECT TENDER IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL RETAIL SALES IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL ONLINE SALES IN ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL ENT DEVICES MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 NORTH AMERICA ENT DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 29 NORTH AMERICA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 30 NORTH AMERICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 31 NORTH AMERICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 32 NORTH AMERICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 33 NORTH AMERICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 34 NORTH AMERICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 35 NORTH AMERICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 36 NORTH AMERICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 37 NORTH AMERICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 38 NORTH AMERICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 39 NORTH AMERICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 NORTH AMERICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 41 NORTH AMERICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 42 NORTH AMERICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 43 NORTH AMERICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 44 NORTH AMERICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 45 NORTH AMERICA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 46 NORTH AMERICA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 47 U.S. ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 48 U.S. TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 U.S. TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 50 U.S. TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 51 U.S. SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 U.S. SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 53 U.S. SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 54 U.S. TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 U.S. TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 56 U.S. TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 57 U.S. EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 58 U.S. EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 59 U.S. EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 60 U.S. LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 61 U.S. LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 62 U.S. LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 63 U.S. ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 64 U.S. ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 65 CANADA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 66 CANADA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 67 CANADA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 68 CANADA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 69 CANADA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 70 CANADA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 71 CANADA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 72 CANADA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 CANADA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 74 CANADA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 75 CANADA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 CANADA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 77 CANADA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 78 CANADA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 CANADA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 80 CANADA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 81 CANADA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 82 CANADA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 83 LATIN AMERICA ENT DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 84 LATIN AMERICA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 85 LATIN AMERICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 86 LATIN AMERICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 87 LATIN AMERICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 88 LATIN AMERICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 LATIN AMERICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 90 LATIN AMERICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 91 LATIN AMERICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 LATIN AMERICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 93 LATIN AMERICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 94 LATIN AMERICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 95 LATIN AMERICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 96 LATIN AMERICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 97 LATIN AMERICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 98 LATIN AMERICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 99 LATIN AMERICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 100 LATIN AMERICA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 101 LATIN AMERICA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 102 BRAZIL ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 103 BRAZIL TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 BRAZIL TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 105 BRAZIL TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 106 BRAZIL SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 BRAZIL SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 108 BRAZIL SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 109 BRAZIL TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 BRAZIL TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 111 BRAZIL TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 112 BRAZIL EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 BRAZIL EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 114 BRAZIL EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 115 BRAZIL LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 BRAZIL LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 117 BRAZIL LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 118 BRAZIL ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 119 BRAZIL ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 120 MEXICO ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 121 MEXICO TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 MEXICO TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 123 MEXICO TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 124 MEXICO SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 125 MEXICO SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 126 MEXICO SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 127 MEXICO TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 MEXICO TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 129 MEXICO TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 130 MEXICO EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 MEXICO EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 132 MEXICO EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 133 MEXICO LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 MEXICO LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 135 MEXICO LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 136 MEXICO ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 137 MEXICO ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 138 COLUMBIA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 139 COLUMBIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 140 COLUMBIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 141 COLUMBIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 142 COLUMBIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 143 COLUMBIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 144 COLUMBIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 145 COLUMBIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 COLUMBIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 147 COLUMBIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 148 COLUMBIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 COLUMBIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 150 COLUMBIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 151 COLUMBIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 152 COLUMBIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 153 COLUMBIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 154 COLUMBIA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 155 COLUMBIA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 156 CHILE ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 157 CHILE TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 158 CHILE TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 159 CHILE TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 160 CHILE SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 161 CHILE SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 162 CHILE SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 163 CHILE TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 164 CHILE TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 165 CHILE TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 166 CHILE EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 167 CHILE EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 168 CHILE EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 169 CHILE LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 170 CHILE LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 171 CHILE LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 172 CHILE ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 173 CHILE ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 174 EMEA ENT DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 175 EMEA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 176 EMEA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 177 EMEA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 178 EMEA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 179 EMEA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 180 EMEA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 181 EMEA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 182 EMEA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 183 EMEA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 184 EMEA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 185 EMEA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 186 EMEA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 187 EMEA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 188 EMEA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 189 EMEA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 190 EMEA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 191 EMEA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 192 EMEA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 193 GERMANY ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 194 GERMANY TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 195 GERMANY TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 196 GERMANY TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 197 GERMANY SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 GERMANY SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 199 GERMANY SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 200 GERMANY TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 201 GERMANY TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 202 GERMANY TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 203 GERMANY EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 GERMANY EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 205 GERMANY EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 206 GERMANY LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 GERMANY LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 208 GERMANY LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 209 GERMANY ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 210 GERMANY ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 211 U.K. ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 212 U.K. TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 U.K. TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 214 U.K. TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 215 U.K. SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 216 U.K. SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 217 U.K. SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 218 U.K. TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 219 U.K. TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 220 U.K. TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 221 U.K. EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 222 U.K. EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 223 U.K. EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 224 U.K. LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 225 U.K. LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 226 U.K. LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 227 U.K. ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 228 U.K. ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 229 FRANCE ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 230 FRANCE TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 231 FRANCE TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 232 FRANCE TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 233 FRANCE SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 234 FRANCE SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 235 FRANCE SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 236 FRANCE TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 237 FRANCE TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 238 FRANCE TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 239 FRANCE EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 240 FRANCE EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 241 FRANCE EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 242 FRANCE LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 243 FRANCE LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 244 FRANCE LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 245 FRANCE ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 246 FRANCE ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 247 SOUTH AFRICA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 248 SOUTH AFRICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 249 SOUTH AFRICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 250 SOUTH AFRICA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 251 SOUTH AFRICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 252 SOUTH AFRICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 253 SOUTH AFRICA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 254 SOUTH AFRICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 255 SOUTH AFRICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 256 SOUTH AFRICA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 257 SOUTH AFRICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 258 SOUTH AFRICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 259 SOUTH AFRICA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 260 SOUTH AFRICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 261 SOUTH AFRICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 262 SOUTH AFRICA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 263 SOUTH AFRICA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 264 SOUTH AFRICA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 265 SAUDI ARABIA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 266 SAUDI ARABIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 267 SAUDI ARABIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 268 SAUDI ARABIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 269 SAUDI ARABIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 270 SAUDI ARABIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 271 SAUDI ARABIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 272 SAUDI ARABIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 273 SAUDI ARABIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 274 SAUDI ARABIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 275 SAUDI ARABIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 276 SAUDI ARABIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 277 SAUDI ARABIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 278 SAUDI ARABIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 279 SAUDI ARABIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 280 SAUDI ARABIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 281 SAUDI ARABIA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 282 SAUDI ARABIA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 283 ASIA-PACIFIC ENT DEVICES MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 284 ASIA-PACIFIC ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 285 ASIA-PACIFIC TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 286 ASIA-PACIFIC TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 287 ASIA-PACIFIC TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 288 ASIA-PACIFIC SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 289 ASIA-PACIFIC SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 290 ASIA-PACIFIC SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 291 ASIA-PACIFIC TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 292 ASIA-PACIFIC TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 293 ASIA-PACIFIC TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 294 ASIA-PACIFIC EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 295 ASIA-PACIFIC EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 296 ASIA-PACIFIC EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 297 ASIA-PACIFIC LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 298 ASIA-PACIFIC LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 299 ASIA-PACIFIC LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 300 ASIA-PACIFIC ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 301 ASIA-PACIFIC ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 302 CHINA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 303 CHINA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 CHINA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 305 CHINA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 306 CHINA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 307 CHINA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 308 CHINA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 309 CHINA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 310 CHINA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 311 CHINA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 312 CHINA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 313 CHINA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 314 CHINA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 315 CHINA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 316 CHINA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 317 CHINA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 318 CHINA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 319 CHINA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 320 INDIA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 321 INDIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 322 INDIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 323 INDIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 324 INDIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 325 INDIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 326 INDIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 327 INDIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 328 INDIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 329 INDIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 330 INDIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 331 INDIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 332 INDIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 333 INDIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 334 INDIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 335 INDIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 336 INDIA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 337 INDIA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 338 JAPAN ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 339 JAPAN TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 340 JAPAN TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 341 JAPAN TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 342 JAPAN SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 343 JAPAN SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 344 JAPAN SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 345 JAPAN TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 346 JAPAN TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 347 JAPAN TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 348 JAPAN EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 349 JAPAN EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 350 JAPAN EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 351 JAPAN LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 352 JAPAN LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 353 JAPAN LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 354 JAPAN ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 355 JAPAN ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 356 AUSTRALIA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 357 AUSTRALIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 358 AUSTRALIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 359 AUSTRALIA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 360 AUSTRALIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 361 AUSTRALIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 362 AUSTRALIA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 363 AUSTRALIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 364 AUSTRALIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 365 AUSTRALIA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 366 AUSTRALIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 367 AUSTRALIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 368 AUSTRALIA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 369 AUSTRALIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 370 AUSTRALIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 371 AUSTRALIA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 372 AUSTRALIA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 373 AUSTRALIA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 374 SOUTH KOREA ENT DEVICES MARKET, BY PROCEDURE TYPE, 2022-2031 (USD MILLION)
TABLE 375 SOUTH KOREA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 376 SOUTH KOREA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 377 SOUTH KOREA TONSILLECTOMY & ADENOIDECTOMY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 378 SOUTH KOREA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 379 SOUTH KOREA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 380 SOUTH KOREA SEPTOPLASTY IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 381 SOUTH KOREA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 382 SOUTH KOREA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 383 SOUTH KOREA TURBINATE REDUCTION IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 384 SOUTH KOREA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 385 SOUTH KOREA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 386 SOUTH KOREA EPISTAXIS IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 387 SOUTH KOREA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 388 SOUTH KOREA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 389 SOUTH KOREA LARYNGEAL IN ENT DEVICES MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 390 SOUTH KOREA ENT DEVICES MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 391 SOUTH KOREA ENT DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
Список рисунков
FIGURE 1 GLOBAL ENT DEVICES MARKET: SEGMENTATION
FIGURE 2 GLOBAL ENT DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL ENT DEVICES MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL ENT DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL ENT DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL ENT DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL ENT DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL ENT DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL ENT DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL ENT DEVICES MARKET: SEGMENTATION
FIGURE 11 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES IS DRIVING THE GROWTH OF THE GLOBAL ENT DEVICES MARKET FROM 2024 TO 2031
FIGURE 12 THE PROCEDURE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ENT DEVICES MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL ENT DEVICES MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING REGION FOR ENT DEVICES MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL ENT DEVICES MARKET
FIGURE 16 GLOBAL ENT DEVICES MARKET: BY PROCEDURE TYPE, 2023
FIGURE 17 GLOBAL ENT DEVICES MARKET: BY PROCEDURE TYPE, 2024-2031 (USD MILLION)
FIGURE 18 GLOBAL ENT DEVICES MARKET: BY PROCEDURE TYPE, CAGR (2024-2031)
FIGURE 19 GLOBAL ENT DEVICES MARKET: BY PROCEDURE TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL ENT DEVICES MARKET: BY END USER, 2023
FIGURE 21 GLOBAL ENT DEVICES MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 22 GLOBAL ENT DEVICES MARKET: END USER, CAGR (2024-2031)
FIGURE 23 GLOBAL ENT DEVICES MARKET: END USER, LIFELINE CURVE
FIGURE 24 GLOBAL ENT DEVICES MARKET: BY DISTRIBUTION CHANNEL 2023
FIGURE 25 GLOBAL ENT DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 26 GLOBAL ENT DEVICES MARKET: DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 27 GLOBAL ENT DEVICES MARKET: DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 28 GLOBAL ENT DEVICES MARKET: SNAPSHOT (2023)
FIGURE 29 GLOBAL ENT DEVICES MARKET: COMPANY SHARE 2023 (%)
FIGURE 30 NORTH AMERICA ENT DEVICES MARKET: COMPANY SHARE 2023 (%)
FIGURE 31 EMEA ENT DEVICES MARKET: COMPANY SHARE 2023 (%)
FIGURE 32 ASIA-PACIFIC ENT DEVICES MARKET: COMPANY SHARE 2023 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
